Takkal, Sofia
Diaz, Luis
Manuel, David
Huang, Qin
Guermazi, Ali http://orcid.org/0000-0002-9374-8266
Article History
Received: 17 January 2022
Revised: 20 March 2022
Accepted: 1 April 2022
First Online: 13 April 2022
Change Date: 25 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00256-022-04063-z
Declarations
:
: The privacy officer at our institution was presented with the de-identified images and the manuscript and subsequently delivered a written approval for the publication of the materials. HIPAA requirements were followed. Informed consent was not required.
: One author (initials blinded for review) reports a conflict of interest that is unrelated to the submitted work: he is a shareholder of BICL, LLC, and a consultant to Pfizer, Novartis, Regeneron, AstraZeneca, Merck Serono, and TissueGene. All other authors have no conflict of interest.